Ideaya Biosciences Inc (IDYA)
Healthcare
Biotechnology
35.50 $
-2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Ideaya Biosciences Inc (IDYA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -75 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -33 | -30 | -24 | -44 | -33 | -49 | -122 | -60 | -62 | 142 | -90 | -75 | -86 | |
| 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.0 | 0.6 | 1.1 | 1.2 | 1.0 | 1.2 | 1.1 | 4.6 | |
| 4.7 | 5.3 | 4.8 | 6.3 | 9.7 | 9.2 | 9.5 | 10 | 12 | 12 | 12 | 15 | 50 | |
| 2.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -8.7 | -5.5 | 8.3 | -5.3 | 16 | -2.3 | 3.4 | 4.2 | 4.6 | 12 | -19 | 8.9 | 6.5 | |
| 0.9 | 0.6 | 0.8 | 1.3 | 1.0 | 0.5 | 1.1 | 1.3 | 0.7 | 0.0 | 0.3 | 1.0 | 2.0 | |
| -121 | 51 | -112 | – | 69 | -20 | -197 | 80 | 46 | 42 | -98 | 119 | 109 | |
| – | – | – | – | – | 9.4 | – | – | – | – | – | 0.0 | – | |
| 191 | 28 | 141 | 349 | 39 | 287 | 2.8 | 26 | 1.2 | 0.3 | 2.1 | 1.2 | 4.8 | |
| 36 | 49 | 5.9 | -49 | 75 | 217 | -316 | 46 | -15 | 184 | -186 | 45 | 28 | |
| -34 | -31 | -25 | -45 | -34 | -50 | -123 | -62 | -63 | 142 | -91 | -76 | -88 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.